Presentation: First Report of Phase Ib/2a Study Evaluating Safety and Early Efficacy of TN-201, an Adeno-Associated Virus Serotype 9 Gene Replacement Therapy, in Adults with MYBPC3 -Associated ...

A weekly programme that illuminates the mysteries and challenges the controversies behind the science that's changing our world.

Sobi® (STO: SOBI), today announced a research collaboration involving a new Phase 2a clinical trial for Gamifant® (emapalumab) for the potential treatment of interferon-gamma (IFNγ)-driven sepsis (IDS ...

Merck , known as MSD outside of the United States and Canada, today announced that new clinical and outcomes research data will be presented at the American College of Cardiology's Annual Scientific ...

The Braiding Knowledges Canada (BKC) Knowledge Braiders’ Award “recognizes impactful research, training, or knowledge mobilization that braids together Indigenous and Western knowledge.” ...